<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00690339</url>
  </required_header>
  <id_info>
    <org_study_id>00201</org_study_id>
    <nct_id>NCT00690339</nct_id>
    <nct_alias>NCT00557674</nct_alias>
  </id_info>
  <brief_title>Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <brief_summary>
    <textblock>
      Safety and effectiveness of Style 410 Silicone-Filled Breast Implants in women undergoing
      primary augmentation, primary reconstruction, or revision of existing breast implants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2001</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local Complications</measure>
    <time_frame>10 years</time_frame>
    <description>By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale.</measure>
    <time_frame>10 years</time_frame>
    <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">941</enrollment>
  <condition>Breast Augmentation</condition>
  <condition>Breast Reconstruction</condition>
  <condition>Revision of Augmentation or Reconstruction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revision-augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revision-reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Style 410 Silicone-Filled Breast Implants</intervention_name>
    <description>Breast Implant Surgery</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, age 18 years or older

          -  Patients seeking primary breast augmentation (i.e., no previous breast implant
             surgery) indicated for the following: Patient dissatisfaction with size or shape of
             breast (e.g., mammary hypoplasia), asymmetry, ptosis, aplasia

          -  Patients seeking breast reconstruction

          -  Patients seeking breast revision-augmentation

          -  Patients seeking breast revision-reconstruction

          -  Adequate tissue available to cover implants

          -  Patients must be willing to undergo MRI at their 1, 3, 5, 7, and 10-year follow-up
             visits (serial MRI). The patient must be eligible for MRI (for example, no implanted
             metal or metal devices and no history of severe claustrophobia that may make her
             ineligible for MRI).

        Exclusion Criteria:

          -  Advanced fibrocystic disease considered to be premalignant without accompanying
             subcutaneous mastectomy

          -  Existing carcinoma of the breast, without mastectomy

          -  Abscess or infection in the body at the time of enrollment

          -  Pregnant or nursing

          -  Have any disease, including uncontrolled diabetes (e.g., Hb AIc &gt; 8%), that is
             clinically known to impact wound healing ability

          -  Show tissue characteristics that are clinically incompatible with mammaplasty, such as
             tissue damage resulting from radiation, inadequate tissue, compromised vascularity or
             ulceration

          -  Have, or under treatment for, any condition that may constitute an unwarranted
             surgical risk (e.g., unstable cardiac or pulmonary problems)

          -  Show psychological characteristics that may be incompatible with the surgical
             procedure and the prosthesis, such as inappropriate attitude or motivation (e.g., body
             dysmorphic disorder)

          -  Are not willing to undergo further surgery for revision, if medically required
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Bengtson BP, Van Natta BW, Murphy DK, Slicton A, Maxwell GP; Style 410 U.S. Core Clinical Study Group. Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg. 2007 Dec;120(7 Suppl 1):40S-48S.</citation>
    <PMID>18090813</PMID>
  </results_reference>
  <results_reference>
    <citation>Gladfelter J, Murphy D. Breast augmentation motivations and satisfaction: a prospective study of more than 3,000 silicone implantations. Plast Surg Nurs. 2008 Oct-Dec;28(4):170-4; quiz 175-6. doi: 10.1097/PSN.0b013e31818ea7e0.</citation>
    <PMID>19092580</PMID>
  </results_reference>
  <results_reference>
    <citation>Maxwell GP, Van Natta BW, Murphy DK, Slicton A, Bengtson BP. Natrelle style 410 form-stable silicone breast implants: core study results at 6 years. Aesthet Surg J. 2012 Aug;32(6):709-17. doi: 10.1177/1090820X12452423. Epub 2012 Jun 29.</citation>
    <PMID>22751081</PMID>
  </results_reference>
  <results_reference>
    <citation>Largent JA, Reisman NR, Kaplan HM, Oefelein MG, Jewell ML. Clinical trial outcomes of high- and extra high-profile breast implants. Aesthet Surg J. 2013 May;33(4):529-39. doi: 10.1177/1090820X13484035. Epub 2013 Apr 4. Review.</citation>
    <PMID>23559355</PMID>
  </results_reference>
  <results_reference>
    <citation>Namnoum JD, Largent J, Kaplan HM, Oefelein MG, Brown MH. Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type. J Plast Reconstr Aesthet Surg. 2013 Sep;66(9):1165-72. doi: 10.1016/j.bjps.2013.04.046. Epub 2013 May 9. Review.</citation>
    <PMID>23664574</PMID>
  </results_reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2008</study_first_submitted>
  <study_first_submitted_qc>June 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2008</study_first_posted>
  <results_first_submitted>December 17, 2013</results_first_submitted>
  <results_first_submitted_qc>December 18, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 4, 2014</results_first_posted>
  <last_update_submitted>October 6, 2014</last_update_submitted>
  <last_update_submitted_qc>October 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Augmentation</title>
          <description>Augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="P2">
          <title>Reconstruction</title>
          <description>Reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="P3">
          <title>Revision-augmentation</title>
          <description>Revision-augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="P4">
          <title>Revision-reconstruction</title>
          <description>Revision-reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="492"/>
                <participants group_id="P2" count="225"/>
                <participants group_id="P3" count="156"/>
                <participants group_id="P4" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="375"/>
                <participants group_id="P2" count="144"/>
                <participants group_id="P3" count="99"/>
                <participants group_id="P4" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
                <participants group_id="P2" count="81"/>
                <participants group_id="P3" count="57"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Augmentation</title>
          <description>Augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="B2">
          <title>Reconstruction</title>
          <description>Reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="B3">
          <title>Revision-augmentation</title>
          <description>Revision-augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="B4">
          <title>Revision-reconstruction</title>
          <description>Revision-reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="492"/>
            <count group_id="B2" value="225"/>
            <count group_id="B3" value="156"/>
            <count group_id="B4" value="68"/>
            <count group_id="B5" value="941"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>subjects</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="492"/>
                    <measurement group_id="B2" value="218"/>
                    <measurement group_id="B3" value="156"/>
                    <measurement group_id="B4" value="65"/>
                    <measurement group_id="B5" value="931"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>subjects</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="492"/>
                    <measurement group_id="B2" value="225"/>
                    <measurement group_id="B3" value="156"/>
                    <measurement group_id="B4" value="68"/>
                    <measurement group_id="B5" value="941"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Local Complications</title>
        <description>By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts</description>
        <time_frame>10 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Augmentation</title>
            <description>Augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
          <group group_id="O2">
            <title>Reconstruction</title>
            <description>Reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
          <group group_id="O3">
            <title>Revision-augmentation</title>
            <description>Revision-augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
          <group group_id="O4">
            <title>Revision-reconstruction</title>
            <description>Revision-reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Local Complications</title>
          <description>By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts</description>
          <units>Percentage of Patients</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="492"/>
                <count group_id="O2" value="225"/>
                <count group_id="O3" value="156"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Capsular Contracture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" lower_limit="6.7" upper_limit="12.6"/>
                    <measurement group_id="O2" value="14.5" lower_limit="10.1" upper_limit="20.6"/>
                    <measurement group_id="O3" value="11.9" lower_limit="7.2" upper_limit="19.3"/>
                    <measurement group_id="O4" value="26.8" lower_limit="16.8" upper_limit="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asymmetry</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" lower_limit="0.5" upper_limit="2.9"/>
                    <measurement group_id="O2" value="12.4" lower_limit="8.4" upper_limit="18.1"/>
                    <measurement group_id="O3" value="6.9" lower_limit="3.6" upper_limit="13.1"/>
                    <measurement group_id="O4" value="17.4" lower_limit="9.6" upper_limit="30.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breast Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="2.8" upper_limit="7.1"/>
                    <measurement group_id="O2" value="8.2" lower_limit="4.9" upper_limit="13.7"/>
                    <measurement group_id="O3" value="5.2" lower_limit="2.3" upper_limit="11.5"/>
                    <measurement group_id="O4" value="7.8" lower_limit="2.9" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrinkling/Rippling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0.3" upper_limit="2.4"/>
                    <measurement group_id="O2" value="6.2" lower_limit="3.3" upper_limit="11.4"/>
                    <measurement group_id="O3" value="3.7" lower_limit="1.5" upper_limit="8.6"/>
                    <measurement group_id="O4" value="12.8" lower_limit="6.1" upper_limit="25.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" lower_limit="0.8" upper_limit="3.3"/>
                    <measurement group_id="O2" value="6.1" lower_limit="3.5" upper_limit="10.7"/>
                    <measurement group_id="O3" value="2.1" lower_limit="0.7" upper_limit="6.3"/>
                    <measurement group_id="O4" value="8.5" lower_limit="3.6" upper_limit="19.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Implant Malposition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" lower_limit="3.1" upper_limit="7.3"/>
                    <measurement group_id="O2" value="5.7" lower_limit="3.1" upper_limit="10.5"/>
                    <measurement group_id="O3" value="9.1" lower_limit="5.2" upper_limit="15.6"/>
                    <measurement group_id="O4" value="8.0" lower_limit="3.0" upper_limit="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" lower_limit="2.5" upper_limit="6.3"/>
                    <measurement group_id="O2" value="5.3" lower_limit="2.8" upper_limit="9.7"/>
                    <measurement group_id="O3" value="2.7" lower_limit="1.0" upper_limit="7.1"/>
                    <measurement group_id="O4" value="3.2" lower_limit="0.8" upper_limit="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroma/Fluid Accumulation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" lower_limit="0.8" upper_limit="3.3"/>
                    <measurement group_id="O2" value="2.8" lower_limit="1.1" upper_limit="6.6"/>
                    <measurement group_id="O3" value="3.2" lower_limit="1.2" upper_limit="8.4"/>
                    <measurement group_id="O4" value="6.2" lower_limit="2.4" upper_limit="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale.</title>
        <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
        <time_frame>10 years</time_frame>
        <population>All patients who had a breast implant satisfaction rating</population>
        <group_list>
          <group group_id="O1">
            <title>Augmentation</title>
            <description>Augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
          <group group_id="O2">
            <title>Reconstruction</title>
            <description>Reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
          <group group_id="O3">
            <title>Revision-augmentation</title>
            <description>Revision-augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
          <group group_id="O4">
            <title>Revision-reconstruction</title>
            <description>Revision-reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale.</title>
          <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
          <population>All patients who had a breast implant satisfaction rating</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="292"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="72"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physician Satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="0.7"/>
                    <measurement group_id="O2" value="4.6" spread="0.8"/>
                    <measurement group_id="O3" value="4.5" spread="1.0"/>
                    <measurement group_id="O4" value="4.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient Satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="0.7"/>
                    <measurement group_id="O2" value="4.6" spread="0.8"/>
                    <measurement group_id="O3" value="4.4" spread="1.1"/>
                    <measurement group_id="O4" value="4.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Augmentation</title>
          <description>Augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="E2">
          <title>Reconstruction</title>
          <description>Reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="E3">
          <title>Revision-augmentation</title>
          <description>Revision-augmentation
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
        <group group_id="E4">
          <title>Revision-reconstruction</title>
          <description>Revision-reconstruction
Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="492"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="225"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="156"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="492"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="225"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="156"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Monitor</name_or_title>
      <organization>Allergan, Inc.</organization>
      <phone>714-246-4500</phone>
      <email>clinicaltrials@allergan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

